A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.
NCT06075615
·
clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Sponsor Decision
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG:
dacomitnib
Sponsor
Pfizer